<DOC>
	<DOC>NCT00740142</DOC>
	<brief_summary>Hypothesis: Is the combination of oral L-ornithine-L-aspartate and lactulose more efficacious than oral lactulose alone in treatment of hepatic encephalopathy? Study design; Randomized, double-blinded, placebo controlled trial</brief_summary>
	<brief_title>Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy</brief_title>
	<detailed_description>Data collection 1. Baseline characteristics - demographic data; age, gender, BW, height - cirrhosis; cause, duration, Child-Pugh score,complications of cirrhosis such as EV, ascites, hepatic encephalopathy, SBP etc. - comorbidity such as DM, CVA 2. After randomization - assessment of mental status (West-Haven criteria), Portal-systemic encephalopathy index (PSEI), number connection test, serum ammonia, asterixis at Day 1,3,7 and EEG at day 1,7 - blood chemistry such as CBC, BUN, Creatinine, electrolyte, LFT, coagulogram, BS at Day 1,3,7 - record adverse effect of drug such as nausea, vomiting, bloating. - record diet, frequency of bowel movement and stool pH - compliance</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>N-Methylaspartate</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<criteria>Cirrhosis Age 1880 Hepatic encephalopathy grade IIIII Serum ammonia &gt; 60 mcg/mL Informed consent Recent GI hemorrhage Severe sepsis Degenerative CNS disease or major psychiatric illness Serum creatinine &gt; 1.5 mg/dl Pregnancy or lactation Poorly controlled DM Insertion of TIPS Received CNS depressants or hypnotics Treatment with metronidazole, kanamycin or branchedchain amino acid Hypersensitivity to LornithineLaspartate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>L ornithine L aspartate</keyword>
	<keyword>Lactulose</keyword>
	<keyword>Hepatic encephalopathy</keyword>
	<keyword>LOLA</keyword>
</DOC>